The Trump administration on Friday proposed two new programs aimed at saving Medicare billions of dollars on seniors' drugs by pegging what the government pays to prices in other developed countries.

The U.S. government on Friday announced pilot programs to start in 2026 and 2027 that are aimed at reducing out-of-pocket drug costs under the Medicare healthcare program for older and disabled Americans to prices on par with economically comparable countries.

(The Hill) — The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion saved compared to last year’s spending.

President Trump announced landmark drug pricing agreements with nine pharmaceutical companies and the launch of TrumpRx.gov, aiming to lower US medicine prices and align them with Europe while warning insurers to cut premiums.

The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about $12 billion. So will the initiative help save money for ...

New abilities for Medicare to negotiate prescription prices mean certain drugs should be 50% to 70% cheaper for many Floridians in 2026.